We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CMS REVIEW NOT SIGNAL TO CURB OFF-LABEL COVERAGE
CMS REVIEW NOT SIGNAL TO CURB OFF-LABEL COVERAGE
February 6, 2004
The Centers for Medicare & Medicaid Services (CMS) isn’t pursuing a wider agenda to curtail Medicare services of widespread, but unapproved, drug treatments despite considering of denying coverage for unapproved uses of two cancer drugs, an agency spokesman said.